Boothbay Fund Management, LLC Adaptive Biotechnologies Corp Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$24.95 - $48.38 $184,630 - $358,012
-7,400 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$16.96 - $34.16 $27,136 - $54,655
-1,600 Reduced 17.78%
7,400 $206,000
Q4 2019

Feb 14, 2020
BUY
$24.56 - $32.8 $221,040 - $295,200
9,000 New
9,000 $269,000

Others Institutions Holding ADPT

# of Institutions
187
Shares Held
152M
Call Options Held
8.4K
Put Options Held
56K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $659M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email